SCHEMBL382962

SCHEMBL382962

N[C@@H](CNC(=O)c1ccc(N2CCC(Nc3ncccn3)CC2)cc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 5/20 0.49
ITGA2B P08514 5/20 0.49
ITGAV P06756 3/20 0.49
DRD2 P14416 6/20 0.44
DRD3 P35462 6/20 0.44
HPGDS O60760 1/20 0.42
CASR P41180 3/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2C Q14957 1/20 0.41
ITGB1 P05556 1/20 0.41
ITGA5 P08648 1/20 0.41
ITGB5 P18084 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
HDAC1 Q13547 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28747046 1.00 ITGB3 (0.49) ITGB3ITGA2BITGAVDRD2DRD3
SCHEMBL7464402 0.89 CNR1 (0.44) ITGB3ITGA2BITGAVDRD2DRD3
SCHEMBL6796554 0.89 ITGB3 (0.49) ITGB3ITGA2BITGAVDRD2DRD3
SCHEMBL382676 0.85 ITGB3 (0.52) ITGB3ITGA2BITGAVGRIN3BGRIN1
SCHEMBL27538781 0.84 ITGB3 (0.42) ITGB3ITGA2BITGAVDRD2DRD3
SCHEMBL7651633 0.84 NPC1 (0.55) ITGB3ITGA2BGRIN3BGRIN1GRIN2C
SCHEMBL381767 0.84 ITGB3 (0.51) ITGB3ITGA2BITGAVDRD2DRD3
SCHEMBL6796225 0.83 CASR (0.44) ITGB3ITGA2BITGAVDRD2DRD3
SCHEMBL6800147 0.83 ITGB3 (0.45) ITGB3ITGA2BITGAVDRD2DRD3
SCHEMBL382099 0.82 ITGB3 (0.54) ITGB3ITGA2BITGAVDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 EP claimed
US-6420558-B1 COMPOUNDS WITH AMIDINE GROUPS ANTAGONISTIC ACTIVITY, CELL ADHESION INHIBITORY ACTIVITY, HUMAN PLATELET AGGREGATION INHIBITORY ACTIVITY, AND THERAPEUTIC AGENTS MEIJI SEIKA KAISHA, LTD. (JP) 2002-07-16 US claimed
EP-1074543-A1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA KAISHA LTD. (JP) 2001-02-07 EP claimed
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 EP disclosed
US-6420558-B1 COMPOUNDS WITH AMIDINE GROUPS ANTAGONISTIC ACTIVITY, CELL ADHESION INHIBITORY ACTIVITY, HUMAN PLATELET AGGREGATION INHIBITORY ACTIVITY, AND THERAPEUTIC AGENTS MEIJI SEIKA KAISHA, LTD. (JP) 2002-07-16 US disclosed
EP-1074543-A1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA KAISHA LTD. (JP) 2001-02-07 EP disclosed